Company profile for Okogen

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Okogen is an ophthalmic specialty pharmaceutical company focused on developing innovative therapies to treat adenoviral conjunctivitis. We believe in addressing both the underlying cause of the disease and treating the associated symptoms. Our lead product candidate, OKG-0502, is being developed to treat adenoviral conjunctivitis (also known as pink eye), a viral infection that affects approximately 30 million people worldw...
Okogen is an ophthalmic specialty pharmaceutical company focused on developing innovative therapies to treat adenoviral conjunctivitis. We believe in addressing both the underlying cause of the disease and treating the associated symptoms. Our lead product candidate, OKG-0502, is being developed to treat adenoviral conjunctivitis (also known as pink eye), a viral infection that affects approximately 30 million people worldwide each year and for which there are no approved therapies.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
332 Encinitas Blvd. Suite 102 Encinitas, CA 92024
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

IPhEB Russia

Not Confirmed

envelop Contact Supplier

IPhEB Russia

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty